Long-lasting protection in brain trauma by endotoxin preconditioning

Area of Science:

• Neuroscience
• Immunology
• Pathology

Background:

• Traumatic brain injury (TBI) is a significant cause of mortality and disability.
• Endotoxin (lipopolysaccharide, LPS) has been shown to induce tolerance to subsequent injuries.
• The neuroprotective potential and mechanisms of LPS preconditioning in TBI remain incompletely understood.

Purpose of the Study:

• To investigate the neuroprotective effects of lipopolysaccharide (LPS) preconditioning in a mouse model of traumatic brain injury (TBI).
• To determine the optimal time window and persistence of LPS-induced protection.
• To elucidate the molecular mechanisms underlying LPS preconditioning in TBI.

Main Methods:

• Mice received LPS or saline intraperitoneally, followed by TBI induced by controlled cortical impact at various time intervals.
• Neurological deficits, contusion volume, and cell death were assessed.
• Gene expression of inflammatory markers, including glial fibrillary acidic protein, CD11b, CD68, tumor necrosis factor-α, IL-10, and IL-6, was analyzed.

Main Results:

• LPS administration 3, 5, or 7 days prior to TBI significantly attenuated motor deficits one week post-injury.
• LPS given 5 days before TBI reduced contusion volume and cell death.
• Neuroprotection, including reduced contusion volume and improved neurological function, persisted for one month.
• LPS preconditioning modulated microglia/macrophage activity (CD11b, CD68) and altered cytokine profiles (interferon β, IL-6) in both uninjured and injured brains.

Conclusions:

• Lipopolysaccharide preconditioning confers significant and long-lasting neuroprotection against traumatic brain injury in mice.
• The protective effects are associated with a specific time window and involve modulation of microglial activation and cytokine production.
• These findings suggest LPS preconditioning as a potential therapeutic strategy for TBI.